Dostarlimab

Unassigned

New Medicines

Stage III or IV ovarian cancer - first-line

Information

New molecular entity
Tesaro
Tesaro

Development and Regulatory status

None
Phase III Clinical Trials
Phase III Clinical Trials

Category

Humanised anti-programmed death-1 (PD-1) monoclonal antibody
Cancer Research UK statistics show that in the UK in 2013 there were 7,284 new cases. Most cases are diagnosed at a late stage [1].
Stage III or IV ovarian cancer - first-line
Intravenous